The mitotic spindle is assembled by the coordinated action of centrosomes and kinetochore microtubules. An evolutionally conserved protein family, transforming acidic coiled-coil (TACC), has been shown to be involved in this process. In humans, TACC3 is aberrantly expressed in a variety of human cancers, but its biological significance remains to be elucidated. Here, using a novel compound targeting TACC3, spindlactone (SPL), we show that the perturbation of TACC3 selectively inhibited the nucleation of centrosome microtubules in ovarian cancer cells. In contrast to centrosome microtubules, the kinetochore microtubules were robustly assembled, forming ectopic spindle poles that resulted in multipolar spindles. Interestingly, the extensive inhibition of TACC3 partially suppressed the nucleation of kinetochore microtubules. These dose-dependent effects of SPL were consistent with the results observed by the depletion of TACC3 and its binding partner, colonic and hepatic tumor overexpressed gene protein (TOGp). Although these proteins both have roles in the assembly of centrosome and kinetochore microtubules, their contributions were spatiotemporally different. Notably, SPL did not affect spindle assembly in normal cells. Furthermore, the oral administration of SPL significantly suppressed tumor growth in vivo. The unique mechanism of action of SPL not only enables it to be used as a tool to dissect the molecular basis of spindle assembly but also to provide a rationale for the use of TACC3 as a molecular target for cancer treatment. This rationale offers an opportunity to develop new strategies for cancer chemotherapy that overcome the limitations of microtubule toxins and expand their scope and clinical efficacy.
INTRODUCTION
The mitotic spindle is a well-established molecular target for cancer chemotherapy, and clinically, drugs targeting microtubules are used to treat hematological and solid malignancies. In tumor cells, the anti-mitotic effects of these drugs are thought to result from the suppression of the dynamic instability of microtubules, which is required for spindle assembly during mitosis. However, these drugs also inhibit microtubule function in non-dividing cells, which results in serious side effects, such as peripheral neuropathy. In addition, resistance to microtubule-targeted drugs is acquired by the overexpression of specific tubulin isoforms. 1 To overcome these problems, new therapeutic agents are being developed to target the mitotic proteins involved in spindle assembly rather than the tubulin itself. 2 Among these mitotic proteins, the motor protein KIF-11, which is also called Eg5; the Aurora kinases; and the Polo-like kinases have been extensively studied as potential drug targets. Although the antitumor activities of these agents have been demonstrated both in vitro and in xenograft models, [3] [4] [5] the scope of their clinical efficacy appears to be limited. 6 Thus, novel therapeutic targets that selectively perturb spindle microtubules without affecting microtubule functions in post-mitotic cells are beneficial to the development of effective therapeutics for cancer treatment.
In vertebrate somatic cells, spindle microtubule nucleation occurs at the centrosome, which contains plus ends that dynamically grow and shrink, probing space until they are captured and stabilized by one of the sister kinetochores on a chromosome. 7 Although this 'search and capture' mechanism appears to be the predominant means by which chromosomes become attached and aligned on the spindle, mathematical modeling studies have indicated that unbiased search and capture alone is not sufficient to align all the chromosomes on the mitotic spindle within a normal timeframe. 8 Growing evidence indicates that in addition to centrosomes, chromosomes also drive spindle assembly. This chromosomedriven mitotic spindle formation was originally thought to function only in meiosis, a process in which centrosomes are not present. However, subsequent studies have indicated that this process works cooperatively with centrosome microtubules to assemble bipolar mitotic spindles in somatic cells. [9] [10] [11] In these systems, kinetochore microtubules support effective spindle assembly by guiding centrosome microtubule growth toward the kinetochores. However, the direct evaluation of kinetochore microtubules in somatic cells is hampered by the mass of centrosome microtubules that rapidly grow after nuclear envelope breakdown (NEB). Thus, the relative contributions of centrosome and kinetochore microtubules to spindle assembly remain to be elucidated.
Human transforming acidic coiled-coil (TACC3) was originally identified within a translocation breakpoint region that was associated with multiple myelomas, 12 and subsequent studies have indicated that it is aberrantly expressed in various cancers. [13] [14] [15] [16] TACC proteins are evolutionally conserved, from yeasts to humans. In Drosophila, a microtubule-associated protein, termed msps, was 1 identified as a binding partner of the D-TACC protein, and their interaction is thought to be critical for the function of TACC proteins in promoting microtubule assembly. 17, 18 A Xenopus homolog of msps, XMAP215, regulates microtubule plus-end assembly and is a processive microtubule polymerase. 19 On the basis of these findings, the current model suggests that TACC proteins recruit msps/XMAP215 to the centrosome, enhancing microtubule polymerization. 20 Interestingly, tumor overexpressed gene protein (TOGp), the human homolog of msps/XMAP215, which was originally identified as a gene that was overexpressed in colon and hepatic cancers, 21 has been shown to physically interact with human TACC3. 18 Furthermore, TOGp depletion has been shown to induce multipolar spindles, but the molecular basis of this action remains under debate. [22] [23] [24] The depletion of TACC3 leads to a range of phenotypes, including a minor decrease in microtubule polymerization, 22 chromosome misalignment leading to caspasedependent apoptosis 25 and declustered centrosomes in cancer cells with supernumerary centrosomes. 26 Using conditional knockout mice, we previously demonstrated that disrupting Tacc3 in lymphoma cells induced the formation of multipolar spindles. 27 Interestingly, an in vivo analysis demonstrated that the thymic lymphoma tissues underwent massive apoptosis, leading to tumor regression, whereas the normal thymus exhibited no overt abnormalities. These observations indicate that Tacc3 is an important component of spindle assembly in cancer cells and is a potential target for cancer chemotherapy. In this study, we developed a novel chemical compound that perturbed TACC3 function. The pharmacological inhibition of TACC3 revealed different spatiotemporal contributions of TACC3 in spindle formation. This unique mechanism of action provides a tool for the investigation of the molecular mechanisms involved in spindle assembly and for the development of new cancer chemotherapy strategies.
RESULTS
The Identification of small compounds that inhibit TACC3 To explore the role of TACC3 in spindle assembly and to develop a novel cancer chemotherapeutic targeting TACC3, we searched for small compounds that were able to inhibit TACC3 function. We utilized a chemical array onto which small compounds obtained from the Natural Products Depository (NPDepo) chemical library had been immobilized (Figure 1a) . 28 Using a cell lysate that expressed a TACC3-DsRed fusion protein as a probe, we screened 6800 compounds and identified 70 as candidate TACC3-interacting molecules.
To determine the effects of the candidate compounds on mitosis, we performed a visual screen using single cell-based analysis. We used ovarian cancer cells because previous studies have indicated that TACC3 is aberrantly expressed in this type of cancer.
14,29 Cells expressing enhanced green fluorescent protein (EGFP)-a-tubulin were synchronized using a double thymidine block, and the candidate compounds were added to the medium at the release from the second block. Fluorescence images were collected, and the image sequences were analyzed to determine the duration of mitosis.
Among the 70 candidates, four small molecules, NPD3574, NPD2568, NPD4089 and NPD2448, induced mitotic arrest in a dosedependent manner (Supplementary Figures S1a, b) . Interestingly, expressing EGFP-a-tubulin were synchronized using a double thymidine block, and the indicated concentrations of the compounds were added at the second release. Time-lapse imaging was then used to determine the fates of single cells. The duration of mitosis was determined from the image sequences of at least 50 cells. (d) Interactions between SPLs and the TACC3-TOGp complex. SPL-A and SPL-B were immobilized on agarose beads and were incubated with the SKOV-3 cell lysates. The indicated proteins bound to the beads were detected using immunoblot analysis. GAPDH was used as a loading control.
Spindle aberration by the TACC3 inhibitor R Yao et al these compounds had similar chemical structures. Each compound had a dicoumarin structure and a hydroxyl group at the C7 position. The hydroxyl group was indispensable for the activity of the compounds, and its propylation completely abolished their activity (Supplementary Figures S1a, b) . On the basis of these results, we then synthesized a series of chemical compounds, and structure-activity relationship studies identified two novel compounds that inhibited the progression of mitosis at different effective doses. The compounds, spindlactone (SPL)-A and SPL-B, both contained an N,N-disubstituted aminomethyl group at the C8 position (Figure 1b) , and SPL-B showed more robust activity (Figure 1c) .
The ability of the SPLs to interact with TACC3 was confirmed using a pull-down assay (Figure 1d ). The SPLs were immobilized on agarose beads with a photoaffinity linker, and SKOV-3 cell lysates were incubated with these beads. Immunoblot analysis revealed the presence of the co-precipitated TACC3 protein on the SPL beads, indicating the binding of the SPLs to TACC3. The intensity of the TACC3 signal was consistently stronger with the SPL-B beads compared with the SPL-A beads. The binding of SPL-A and SPL-B to TACC3 was not nonspecific because other microtubule-binding proteins, such as NDC80, MCAK and TPX2 as well as GAPDH, were barely detectable in the compound-loaded beads. Interestingly, both types of SPL beads also pulled down the TOGp protein, suggesting that the TACC3-TOGp complex binds to SPL-A. Further analysis of TACC3-interacting molecules indicated that Aurora-A and b-tubulin were also pulled down by the compound-loaded beads. These observations suggested that SPL-A and SPL-B bind directly or indirectly to TACC3 and its interacting proteins.
To further investigate the interaction between SPL-A and TACC3 proteins, we performed the pull-down experiment after the depletion of TACC3 and found that TACC3 depletion significantly reduced the binding of TOGp protein to the compound-loaded beads (Supplementary Figure S2) . The residual binding may be potentially due to the incomplete deletion of TACC3 protein. In contrast, TOGp depletion did not alter the binding of TACC3 protein to SPL-A, although the total amount of TACC3 protein was increased, which was most likely due to the mitotic arrest induced by TOGp depletion. These observations suggested that the interaction between TOGp with the compound was mediated, at least in part, by TACC3. However, the depletion of TACC3 led to robust alteration in the spindle structure, and the reduced binding of TOGp may be an indirect effect caused by TACC3 depletion. The precise mode of interaction needs to be further elucidated.
SPLs induce aberrant spindles in ovarian cancer cells in a dosedependent manner Next, we examined the effects of the SPLs on spindle assembly in SKOV-3 cells. Immunofluorescence analysis revealed that SPL-A treatment induced the formation of multipolar spindles. At a concentration of 1.25 mg/ml, 53.3% of the SKOV-3 cells contained multipolar spindles (Figure 2a ). SPL-B essentially induced identical phenotypes, albeit with different dosage effects (Supplementary Figure S3) . Another ovarian cancer cell line, OVCAR-3, exhibited similar spindle aberrations when treated with SPL-A, which suggested that the spindle aberrations induced by SPL-A treatment were not limited to SKOV-3 cells. g-Tubulin was localized to each spindle pole, whereas centrin 2 was detected at only two (Figure 2b ). These observations indicated that the multipolar spindles were not induced by the overproduction of centrosomes or by cytokinesis failure following the previous round of mitosis. Notably, SPL-A treatment did not alter the localization of TACC3 or TOGp (Figure 2c ). Consistent with this finding, SPL-A did not prevent the phosphorylation of TACC3 at Ser558, which was shown to be phosphorylated by Aurora-A and to mediate the localization of TACC3 to mitotic spindles (Supplementary Figure S4) .
The spindle aberrations in ovarian cancer cells induced by SPL-A treatment were much stronger than the findings previously reported in TACC3-depleted HeLa cells. Therefore, we examined the effects of SPL-A in HeLa cells and found that, in contrast with ovarian cancer cells, no overt spindle abnormalities were induced (Supplementary Figure S5) . However, a close examination of chromosomes revealed that they were not properly aligned at the metaphase plates, and the percentages of cells containing misaligned chromosome were increased in a dose-dependent manner. This phenotype highly resembled to that reported in TACC3-depleted HeLa cells. These observations demonstrated that the effect of SPL-A depends on the cell types.
To address the mechanisms underlying the formation of multipolar spindles induced by SPL-A treatment, EGFP-a-tubulin and mCherry-CENP-A were expressed in ovarian cancer cells, and the dynamics of spindle assembly in these cells were examined using time-lapse imaging. In the control cells, two intense EGFP-a-tubulin signals associated with centrosomes were evident at the onset of NEB (Figure 2d , control). These microtubules grew rapidly and formed bipolar spindles. When the cells were treated with SPL-A, two centrosome-associated microtubules were apparent at NEB (Figure 2d , multipolar). However, the intensities of these two microtubules were decreased following NEB, which indicated that SPL-A perturbed the nucleation and growth of centrosome microtubules. Intriguingly, the nucleation and polymerization of a-tubulin was evident near centromere protein A (CENP-A) at the onset of NEB. An immunofluorescence analysis indicated that in contrast to the centrosome microtubules, these spindles contained microtubules that were resistant to calcium treatment and were attached to kinetochores, suggesting that they were chromosome-driven microtubules (Supplementary Figure S6 ). These microtubules were nucleated and grew rapidly in SPL-A-treated cells. The centrosomes were integrated into the kinetochore microtubules during late prometaphase (Figure 2d , multipolar, 12 min) but did not coalesce at the ectopic spindle poles, thereby resulting in multipolar spindles. These observations demonstrate that SPL-A severely perturbed the nucleation and elongation of centrosome microtubules, whereas the chromosome-driven microtubules were assembled. In control cells, the chromosome-driven microtubules were rapidly integrated into the mass of centrosome microtubules; therefore, the evaluation of SPL-A effects on the chromosome-driven microtubule nucleation was difficult.
In addition to multipolar spindles, SPL-A also induced disorganized spindles. These spindles consisted of two poles but the intensities of a-tubulin were lower than those in control cells. In addition, the chromosomes were not properly aligned at the metaphase plate ( Figure 2b ). The disorganized spindles were most frequently observed following SPL-A treatment at a concentration of 5 mg/ml in SKOV-3 cells (56.7%) and 2.5 mg/ml in OVCAR-3 cells (57.3%) (Figure 2a ). Time-lapse imaging revealed that the centrosome microtubules failed to grow after NEB (Figure 2d , disorganized), a result that is similar to those observed in the multipolar spindle formation. In addition, the nucleation and polymerization of kinetochore microtubules was significantly delayed compared with those in multipolar spindle formation. The centrosomes were captured and integrated into the kinetochore microtubules before they assembled ectopic spindle poles, resulting in bipolar spindles. These observations demonstrated that SPLs inhibited the nucleation of the centrosome and kinetochore microtubules in a dose-dependent manner.
At Spindle aberration by the TACC3 inhibitor R Yao et al microtubules, two centrosomes were moved toward the center of the cell and eventually became monopolar spindles (Supplementary Figure S7) . These observations indicated that the severe perturbation of microtubule nucleation by high concentrations of SPL-A led to a reduction of centrosome ejection force.
Centrosome microtubule assembly requires TACC3 function The depletion of TACC3 function in mammalian cells has been shown to lead to a range of spindle defects that are distinct from the findings observed in SPL-A-treated cells, with the exception of the occurrence of multipolar spindles in TACC3-depleted lymphoma cells. 22, [25] [26] [27] Next, we investigated the role of TACC3 in ovarian cancer cells. When cells were transfected with TACC3-specific small interfering RNA (siRNA) oligonucleotides, the TACC3 protein levels were reduced to 18.2 and 15.2% in the SKOV-3 and OVCAR-3 cells, respectively, compared with the cells transfected with control siRNA oligonucleotides (Figure 3a ). An immunofluorescence analysis revealed the accumulation of multipolar spindles in the cells depleted of TACC3 (Figures 3b, c) . Sixtypercent of the SKOV-3 cells and 69% of the OVCAR-3 cells contained multipolar spindles 24 h after transfection with TACC3 siRNA. Each spindle pole contained g-tubulin but only two of these poles contained centrin 2 (Figures 3b-d) . Furthermore, time-lapse imaging analysis revealed that TACC3 deprivation selectively inhibited the nucleation of centrosome microtubules, whereas kinetochore microtubules rapidly grew and polymerized, leading to ectopic spindle poles (Figure 3e, multipolar) . Thus, the depletion of TACC3 led to the formation of multipolar spindles by selectively inhibiting the nucleation of centrosome microtubules. These observations indicated that SPL-A treatment recapitulated the spindle aberrations induced by TACC3 depletion, supporting the notion that SPL-A perturbed spindle assembly by targeting TACC3 function.
Although multipolar spindles were the major aberration of the mitotic spindle in response to TACC3 depletion, a small but significant number of cells contained disorganized spindles. This finding was observed in 17 and 15% of SKOV-3 cells and OVCAR-3 cells, respectively (Figures 3b, c) . Although these spindles contained two centrosomes, the intensity of microtubules was lower than the intensity observed in normal bipolar spindles, and the chromosomes were not correctly aligned at the metaphase plates (Figure 3b ). Time-lapse imaging revealed that the disorganized spindles resulted from the inhibition of both the kinetochore microtubules and the centrosome microtubules (Figure 3e ). These observations indicate that although TACC3 had a major role in the nucleation of centrosome microtubules, it also contributed to the nucleation of kinetochore microtubules.
The observations described above indicated that TACC3 contributed to spindle assembly at spatially distinct sites; therefore, we investigated the subcellular localization of TACC3 during mitosis. TACC3-mCherry was expressed in SKOV-3 cells with EGFPa-tubulin, and its localization was examined using time-lapse imaging (Supplementary Figure S8) . At the onset of NEB, TACC3 accumulated rapidly around the centrosomes, suggesting that it has a role in the nucleation of centrosome microtubules. At this time, TACC3 was not detected in kinetochore microtubules. However, 5 min after NEB, TACC3 was recruited to kinetochore microtubules that were in close proximity to centrosomes and that were about to be integrated into centrosome microtubules (Supplementary Figure S8 , 5 min, arrowheads in inset). These observations are consistent with the idea that TACC3 has dominant roles in the nucleation of centrosome microtubules at NEB and additional roles involving kinetochore microtubules at later stages. These results may explain the disorganized spindles that were present in the cells treated with higher doses of SPL-A.
TOGp depletion induced monopolar spindles that recapitulated the spindles observed at high concentrations of SPL-A The spindle aberrations induced by SPL-A treatment recapitulated the phenotypes observed in TACC3-depleted cells, suggesting that SPL-A induced aberrant spindles by targeting TACC3. However, monopolar spindles were not observed in TACC3-depleted cells. Monopolar spindles were only observed at high doses of SPL-A; therefore, they may be induced via TACC3-independent mechanisms. Alternatively, because cells transfected with siRNA targeting TACC3 still expressed a significant amount of TACC3 protein (Figure 3a) , its depletion may not have been sufficient to induce monopolar spindles. To address this issue, we depleted TOGp in ovarian cancer cells because TOGp was a critical protein involved in TACC3-mediated nucleation of microtubules. 20 In addition, our pull-down experiments in ovarian cancer cells indicated that TACC3-TOGp as a complex binds to SPL-A (Figure 1d ). Transfection with TOGp-specific siRNA oligonucleotides reduced the level of TOGp protein to 16.8 and 6.2% of its levels in SKOV-3cells and OVCAR-3 cells, respectively, compared with the cells transfected with control siRNA oligonucleotides (Figure 4a) .
Consistent with previous reports, [22] [23] [24] 30 we found that 30% of the TOGp-depleted SKOV-3 cells contained multipolar spindles (Figure 4b ). Similar to the observations in TACC3-depleted cells, each spindle pole contained g-tubulin, whereas centrin 2 was localized to only two spindle poles (Figure 4c ). In addition to the observed multipolar spindles, 36% of the cells contained disorganized bipolar spindles (Figure 4b ). These spindles consisted of two poles, but their a-tubulin intensities were weaker compared with normal bipolar spindles, and the chromosomes were not properly aligned at the metaphase plate (Figure 4c ). These observations demonstrated that TOGp had prominent roles in the nucleation of kinetochore microtubules in addition to centrosome microtubules. Interestingly, in OVCAR-3 cells, 69% of the cells exhibited monopolar spindles in response to TOGp depletion (Figure 4b ). An immunofluorescence analysis revealed that these spindles contained two centrosomes and centrioles and were similar to the findings observed in SPL-A-treated cells (Figure 4d ). These observations support the idea that SPL-A induced monopolar spindles by perturbing TOGp-mediated spindle assembly. In addition, monopolar spindles were only observed in OVCAR-3 cells, and this finding was consistent with the result demonstrating that OVCAR-3 cells were more sensitive to the SPL-A treatment compared with SKOV-3 cells (Figure 2a) . SPL selectively inhibits mitosis in cancer cells and suppresses in vivo tumor growth The results described above demonstrated that in the ovarian cancer cells that expressed a high level of TACC3, TACC3 was indispensable for spindle assembly. Therefore, we examined TACC3 function in normal cells to explore the potential of TACC3 as a molecular target for cancer treatment. Consistent with the results obtained by siRNA transfection, the depletion of TACC3 using lentivirus-mediated small hairpin RNA expression significantly induced mitotic arrest in SKOV-3 cells and in OVCAR-3 cells (Figures 5a, b) . In contrast, despite efficient reductions of TACC3 protein levels, three normal cell lines, hTERT-RPE, MCF10A and 184B5, exhibited no overt alterations in mitosis. Next, we found that SPL-A specifically induced mitotic arrest in cancer cells (Figure 5c ). Interestingly, the specific induction of mitotic arrest in cancer cells was not observed with microtubule toxins as well as with small compounds that inhibit mitotic proteins, such as Aurora and Polo-like kinases and the motor protein, Eg5 (Supplementary Figure S9) . These observations demonstrated that the unique mechanism of action of SPL conferred selective perturbation of spindle assembly in ovarian cancer cells.
To evaluate the role of TACC3 in tumor proliferation in vivo, we examined the ability of SPL-B to suppress the growth of SKOV-3 cell xenografts in nonobese diabetic/severe combined immunodeficient mice. Similar to findings observed with SPL-A, SPL-B selectively induced mitotic arrest in ovarian cancer cells (Supplementary Figure S10) . SPL-B exhibited excellent oral bioavailability, and 6 h after the oral administration of 20 mg/kg of SPL-B, its plasma concentration was 270 ng/ml, whereas the concentration of intraperitoneally administered SPL-B was 90 ng/ ml. Cells were injected subcutaneously into animals, which were Spindle aberration by the TACC3 inhibitor R Yao et al subsequently treated with SPL-B via oral administration. In mice treated with a single administration of SPL-B at a concentration of 10 mg/kg, the percentage of cells positive for histone H3 phosphorylation was significantly increased (1.2% and 2.1% in dimethyl sulfoxide and SPL-B-administered mice, respectively; Po0.001) (Figure 5d ), indicating that SPL-B induced mitotic arrest in vivo.
The tumor volumes of mice treated twice a day for 14 days with 10 mg/kg SPL-B were reduced by 48% (Po0.002) in comparison with the control group (Figure 5e ). Tumor growth reduction was dose-dependent and was significant at a dosage of 2.5 mg/kg (69%, Po0.05). SPL-B was well tolerated at a dose of 10 mg/kg, and no significant decrease in the body weight of the mice was observed (Figure 5f ). These observations demonstrated the potential utility of SPL-B as a chemotherapeutic agent for cancer treatment.
DISCUSSION
TACC3 is aberrantly expressed in human cancers and is considered to be a potential molecular target for cancer chemotherapy. Using conditional knockout mice, we previously demonstrated that the disruption of TACC3 led to tumor regression, whereas normal tissues exhibited no overt abnormalities. 27 Therefore, small compounds that inhibit TACC3 function may be beneficial in developing new strategies for cancer chemotherapy. However, the development of these types of compounds has been hampered by the lack of an in vitro measure of the biochemical activity of TACC3. In this study, using chemical array screening followed by visual screening, we identified several novel chemical compounds, SPLs. Although the pull-down experiments indicated that SPLs bound to TACC3, we do not know whether this binding occurred directly or indirectly. However, we showed that the phenotypes induced by low concentrations of SPLs are highly similar to the phenotypes induced by TACC3 depletion, and the dosedependent effects of SPL on spindle assembly were well correlated with TACC3 and TOGp depletion. These observations provide evidence that SPLs induce aberrant spindles by perturbing the nucleation of microtubules involved in TACC3 function. To formally prove that the inhibition of TACC3 is responsible for the spindle aberrations observed, it will be necessary to determine the structure of the SPL-TACC3 complex and/or to identify mutations in TACC3 that render it resistant to SPLs. 31 We have shown that the depletion of TACC3 selectively inhibited the nucleation of centrosome microtubules. Notably, the robust nucleation of chromosome-driven microtubules was observed in the absence of TACC3 (Figure 3e ). Although several lines of evidence indicate that kinetochore microtubules operate in mammalian somatic cells after recovery from microtubule toxins and cold treatment, 9, 32, 33 their kinetics and dynamics under physiological conditions and at the onset of NEB remain largely unknown. Centrosome-independent mitotic spindle formation was previously described in green monkey fibroblasts in which the centrosomes had been destroyed with laser microsurgery. 11 It should be noted that this laser treatment destroyed centrosomes as organelles, and the centrosomal proteins were distributed elsewhere in the cytoplasm, whereas our approach specifically depleted TACC3 without affecting other centrosomal components. This difference creates difficulty in directly comparing centrosome-independent microtubule assembly in TACC3-depleted cells versus cells in which the centrosomes had been destroyed. The kinetochore microtubules were observed in the presence of centrosome microtubules (Supplementary Figure S8) , confirming a previous report. 10 We noticed that in the absence of TACC3, the nucleation and polymerization of kinetochore microtubules was strikingly more extensive than in the presence of TACC3 activity. This difference may indicate that the mass of centrosome microtubules rapidly incorporates kinetochore microtubules, which makes their visualization difficult. It is also possible that tubulin proteins are abundantly present in the absence of centrosome microtubules, leading to the robust nucleation and polymerization of kinetochore microtubules. Our system of visualizing kinetochore microtubule assembly provides a unique and valuable tool for investigating the kinetics and dynamics of kinetochore spindle assembly and its molecular mechanisms.
In HeLa cells, the depletion of TACC3 does not induce overt spindle aberrations, whereas TOGp depletion induces multipolar spindles. 22, 24 However, the molecular basis of these differences remains to be clear. In this study, we demonstrated that a major phenotype of TACC3 perturbation is the inhibition of the centrosome microtubule nucleation. We also showed that TOGp has more profound roles in the assembly of kinetochore microtubules. Interestingly, SPLs inhibit spindle assembly in a dose-dependent manner. For example, at low concentrations, SPLs only perturbed the nucleation of centrosome microtubules, whereas at high concentrations, SPLs also inhibited kinetochore microtubule assembly. One possible explanation for these observations is that the nucleation of centrosome microtubules requires higher microtubule polymerization activity compared with kinetochore microtubules, suggesting that the TACC3-TOGp complex has spatiotemporally different contributions to spindle assembly. These observations support the current model that TACC3 facilitates spindle assembly by stimulating TOGp microtubule polymerization activity; therefore, the depletion of TOGp exhibited a more drastic phenotype than TACC3 depletion. In this study, we did not observe any alterations in the cellular localization of TOGp in response to TACC3 depletion or vice versa. Similarly, SPLs did not change the cellular localization of TACC3 or TOGp. Further analysis regarding the mechanism by which SPLs inhibit TACC3 function and perturb the nucleation and polymerization of microtubules will provide clues for a better understanding of spindle assembly.
Our present work demonstrates that TACC3 depletion induces mitotic arrest in ovarian cancer cells but not in normal cells and is consistent with previous studies showing that oncogenic changes may drive TACC3 dependency for spindle assembly. 27, 34 We demonstrated that the robust nucleation and elongation of kinetochore microtubules induced ectopic spindle poles, which led to multipolar spindles. These observations suggested that in cancer cells, the elevated polymerization activity of kinetochore microtubules as well as their pole-focusing activity might contribute to the cellular context-dependent sensitivity to TACC3 depletion. In fact, several of the kinetochore components, including the Ndc80 complex, Zwint and Aurora B, are aberrantly expressed in various cancers. [35] [36] [37] Recently, NuMA, which localizes microtubules at the poles and tethers them to centrosomes, 38 was shown to be highly expressed in ovarian cancers. 39 These molecules may also contribute to the selective inhibition of cancer cells by SPLs. Overall, the unique mechanism of the action of SPLs not only aids in the dissection of the molecular basis of spindle assembly but also provides a rationale for the use of TACC3 as a molecular target for cancer treatment. This finding offers an opportunity to develop new strategies for cancer chemotherapy with expanded scope and clinical efficacy.
MATERIALS AND METHODS

Chemical array screening
Human TACC3 complementary DNA was cloned into the pDsRed-Express-N1 vector, which was transfected into 293T cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). At 48 h after transfection, the cell pellet was collected and suspended in phosphate-buffered saline. Cell lysates were prepared by sonication and by centrifugation to remove any insoluble materials. The expression of the TACC3-DsRed fusion protein was detected by immunoblot analysis using antibodies against TACC3 and DsRed (Clontech, Mountain View, CA, USA). The cell lysates were incubated with the chemical array slides for 1 h at 4 1C in a hybridization chamber. 28 The cell lysates obtained from the DsRed-expressing cells were used as a control. After three washes with ice-cold phosphate-buffered saline, the slides were dried and scanned on a GenePix microarray scanner at an excitation wavelength of 532 nm and an emission wavelength of 575 nm.
SPL preparation
Spindlactone A.
Formaldehyde (37% in H 2 O) (17.7 ml, 240 mmol) and 4-piperidineethanol (9.7 mg, 75.0 mmol) were added to a stirred solution of dicoumarin (9.2 mg, 30.0 mmol) in acetonitrile (3.5 ml) at room temperature. The stirred reaction mixture was heated under reflux for 27 h. The mixture was cooled to room temperature, concentrated and diluted with CHCl 3 . The organic layer was washed with H 2 O and brine, dried (Na 2 SO 4 ) and concentrated. The resulting yellow oil was purified twice with preparative thin-layer 
Binding of SPLs to TACC3 and TOGp
SPLs immobilized on agarose beads were prepared as previously described. 40 SKOV-3 cell lysates were prepared by sonication in binding buffer (10 mM Tris-HCl, pH 7.5, 50 mM KCl, 5 mM MgCl 2 , 1 mM EDTA and a protease inhibitor cocktail (Roche, Basel, Switzerland)). After the insoluble materials were removed by centrifugation, the supernatants (500 mg of protein) were incubated with 30 ml of beads for 3 h at 4 1C. The bound beads were washed four times with binding buffer containing 0.025% NP-40, and the bound proteins were eluted in SDS-polyacrylamide gel electrophoresis sample buffer. Next, the samples were analyzed by immunoblot analysis. An anti-NADPH antibody was used as a control.
Time-lapse imaging
Cells were transfected with siRNA oligonucleotides and plated on 60-mm glass-bottom plates (IWAKI, Tokyo, Japan). At 16 h after transfection, 150 ml of a CellMatrix gel (Nitta Gelatin, Osaka, Japan) was overlaid to minimize the movement of cells during mitosis, and 150 ml of Roswell Park Memorial Institute medium 1640 medium supplemented with 10% fetal bovine serum was added. Fluorescence images were acquired every 2 min using a Leica AF6000 fluorescence microscope with a 63 Â /1.40-0.70 Plan APO objective lens. Z-projections are shown in Figures 2 and 3 .
For the analysis of cell fates, the cells were seeded onto 96-well opticalbottom plates (Nunc, Roskilde, Denmark) and treated with 2.5 mM thymidine for 16 h, followed by incubation in thymidine-free fresh medium for 8 h. During this period, the cells were transfected with siRNA oligonucleotides as described above. The cells were then treated again with 2.5 mM thymidine for 16 h. Images were collected using a Leica AF6000 with a 20 Â /0.5 Plan Fluotar objective lens every 10 min for 3 days in phenol red-free Roswell Park Memorial Institute medium 1640 medium supplemented with 5% fetal bovine serum. The image sequences were viewed using ImageJ 1.42a software (National Institute of Health, Bethesda, MD, USA), and the cell fates were determined manually.
Cell lines and transfection of siRNA SKOV-3 cells and OVCAR-3 cells were cultured in Roswell Park Memorial Institute medium 1640 medium supplemented with 5% fetal bovine serum. 41 hTERT-RPE cells were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum, and MCF10A and 184B5 cells were cultured in MEGM supplemented with 100 ng/ml and 1 ng/ml cholera toxin, respectively. Stable clones that constitutively expressed EGFP-a-tubulin (Clontech) were obtained via lentiviral transduction using the pLenti4/V5-DEST vector (Invitrogen). Infected cells were selected using Zeocin, followed by limiting dilution cloning. Cell lines that expressed mCherry-CENP-A or mCherry-TACC3 were obtained by infecting EGFP-a-tubulin-expressing cells with pLenti6/V6-DEST (Invitrogen) and were selected using blasticidin S HCl (Invitrogen).
The control siRNA and siRNAs specific for TACC3 and TOGp were obtained from Invitrogen. Cells were transfected with these siRNAs using Lipofectamine RNAiMAX in accordance with the manufacturer's instructions. Three sequences were tested for each target, and at least two sequences were required to exhibit similar effects on gene silencing and mitosis for the target to be considered valid.
Immunoblotting
The antibody against TACC3 was generated by immunizing rabbits with a peptide corresponding to the amino acids 213-224 of human TACC3. The rabbit anti-TOGp antibody was raised against the C-terminal 111 amino acids of human TOGp fused to glutathione S-transferase. Affinity-purified antibodies were used in this study. The anti-GADPH antibodies (sc-25778) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). The phospho-TACC3 (Ser558) (D8H10) and anti-Aurora-A (1G4) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). The anti-btubulin (ab6046) antibody and NDC80 (9G3.23) were purchased from Abcam (Cambridge, UK) and Novus Biologicals (Cambridge, UK), respectively.
Total cell lysates were prepared in 1% NP-40 buffer (1% NP-40, 50 mM Tris-HCl, pH 8.0, 150 mM NaCl and 10% glycerol). Equal amounts of proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The blots were incubated with primary antibodies, followed by the incubation with horseradish peroxidaseconjugated secondary antibodies and visualization using an enhanced chemiluminescence detection system (GE Healthcare, Buckinghamshire, UK). For quantitation, the blots were scanned, and the total pixel intensity was calculated using ImageJ 1.42a software and normalized to the total pixel intensity of the GADPH control.
Immunofluorescence
The cells were cultured on chamber slides and fixed in 3.7% PFA, 100% methanol or 10% TCA, as previously described. 42, 43 They were then incubated with primary antibodies. Monoclonal antibodies against a-tubulin (DM1A) and g-tubulin (DQ19 and GTU88) were obtained from Sigma. Anti-pericentrin and anti-Aurora-A antibodies were purchased from Covance (Princeton, NJ, USA) and TransGenic (Kumamoto, Japan), respectively. Anti-centrin 2 (sc-27793) was obtained from Santa Cruz Biotechnology. Fluorescein-conjugated goat anti-mouse IgG (Cappel, Solon, OH, USA) and Cy3-conjugated goat anti-rabbit IgG (Millipore, Temecula, CA, USA) were used as secondary antibodies. DNA was detected using 4,6-diamidino-2-phenylindole. Imaging was performed using a Leica DM6000B upright microscope equipped with a Â 100/1.40-0.70 Plan APO objective lens. Z-projections are shown in Figures 2-4 .
Lentiviral infection and FACS analysis
Cells were transduced with pLKO.1-puro lentiviral small hairpin RNA targeting TACC3 (TRCN000062023-7, Thermo Scientific, Hudson, NH, USA). The representative results using TRCN000062026 are presented in Figure 5 .
The lentiviral particles were produced by the co-transfection of 293T cells with the pLKO.1 constructs and the pMD2.G and psPAX2packaging plasmids. The transfections were conducted using Lipofectamine 2000 (Invitrogen), and the virus was harvested at 48 and 72 h after transfection. The cells were incubated with the lentiviral supernatants in the presence of 6 mg/ml polybrene for 24 h, and the infected cells were selected with 1-8 mg/ml puromycin. At 48 h after infection, the cells were collected, fixed in ethanol and analyzed using flow cytometry after staining with propidium iodide.
Animal experiments and immunohistological analysis
All animal studies and procedures were approved by the Japanese Foundation for Cancer Research (JFCR) Cancer Institute Animal Committee (Japan). For the xenograft tumor models, 1 Â 10 7 SKOV-3 cells were injected subcutaneously into each flank of nonobese diabetic/severe combined immunodeficient mice. The mice were treated with 50 ml of SPL-B dissolved in dimethyl sulfoxide by oral administration every 2 days, and the tumor volumes were scored. Dimethyl sulfoxide was administered as a control using the same procedure.
Tissues were collected, fixed in 10% buffered formalin (Wako, Osaka, Japan) and paraffin-embedded. Next, 1-, 4-or 6-mm sections were prepared. Immunohistochemical analysis was performed as previously described. 27 
